2017-10-26T10:53:57-05:00 2016-12-31 410746749 CLIFTONLARSONALLEN LLP 901 N GLEBE ROAD SUITE 200 ARLINGTON VA 22203 990 2016-01-01 264188804 COUNCIL FOR BIOTECHNOLOGY INFORMATION COUN 2029629200 1201 MARYLAND AVENUE SW NO 900 WASHINGTON DC 20024 ROBYN HEINE EXECUTIVE COMMITTEE CHAIR 2029629200 2017-10-16 1 MARY ANNE HAKIM P00236052 5712279500 2016 2022-09-23 18:48:47Z ROBYN HEINE 1201 MARYLAND AVENUE SW NO 900 WASHINGTON DC 20024 3970902 0 X WWW.GMOANSWERS.COM X 2008 DC TO PROMOTE AGRICULTURAL PLANT BIOTECHNOLOGY THROUGH THE EXCHANGE OF INFORMATION ABOUT ITS BENEFITS AND SAFETY AND THROUGH RESEARCH, EDUCATION, ADVOCACY AND OTHER MEANS IN THE UNITED STATES AND GLOBALLY VIA THE INTERNET. 6 6 0 6 0 0 0 0 8430000 3970000 4216 902 0 0 8434216 3970902 3040602 5000 0 0 0 0 0 0 0 7619916 4076201 10660518 4081201 -2226302 -110299 1093651 1099016 78480 194144 1015171 904872 TO PROMOTE AGRICULTURAL PLANT BIOTECHNOLOGY THROUGH THE EXCHANGE OF INFORMATION ABOUT ITS BENEFITS AND SAFETY AND THROUGH RESEARCH, EDUCATION, ADVOCACY AND OTHER MEANS IN THE UNITED STATES, CANADA, AND MEXICO. 0 0 GMO ANSWERS - CONTINUED DEVELOPMENT AND EXPANDED OUTREACH FOR THE GMO ANSWERS PROGRAM AND WEBSITE. INTERNATIONAL PROGRAMS - DEVELOPED PROGRAMS TO PROMOTE ACCEPTANCE OF AGRICULTURAL BIOTECHNOLOGY. EXTERNAL VOICES - WORKED WITH EXTERNAL PARTNERS FOR EDUCATION, TRAINING, AND LEADERSHIP DEVELOPMENT. 0 0 0 1 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 7 0 1 0 0 0 0 0 0 0 X 6 6 0 1 0 0 1 1 0 1 1 0 0 1 1 1 1 1 1 1 0 0 X THE ORGANIZATION 2029629200 1201 MARYLAND AVENUE SW NO 900 WASHINGTON DC 20024 X JERRY FLINT DIRECTOR 0.20 X 0 0 0 RICK VAN GENDEREN DIRECTOR 0.20 X 0 0 0 PHIL MILLER DIRECTOR 0.20 X 0 0 0 ROBYN HEINE DIRECTOR 0.20 X 0 0 0 NAOMI STEVENS CHAIR 0.20 X X 0 0 0 PAUL MINEHART DIRECTOR 0.20 X 0 0 0 KATE HALL ACTING EXECUTIVE DIRECTOR 37.50 X 0 0 0 0 0 0 0 0 0 1 KETCHUM INC 6 PPG PLACE 12TH FLOOR PITTSBURGH PA 15222 PUBLIC RELATIONS CONSULTANTS 2978500 BIOTECHNOLOGY INNOVATION ORGANIZATION 1201 MARYLAND AVE STE 900 WASHINGTON DC 20024 MANAGEMENT SERVICES 329702 CROPLIFE CANADA 21 FOUR SEASONS PLACE SUITE 627 ETOBICOKE ONTARIO CA M9B 6J8 PROJECT MANAGEMENT 255000 3 DUES AND SPECIAL ASSES 900099 3970000 3970000 3970000 902 902 3970902 3970000 0 902 X 5000 257126 14407 51202 3338800 30456 30372 39684 24277 260290 12582 SPONSORSHIPS 15000 EDUCATION, TRAINING, SE 2005 4081201 64711 314449 497075 495479 111148 17002 1008012 740932 416447 267080 4270 5006 1093651 1099016 24324 106460 54156 87684 78480 194144 X 1015171 904872 1015171 904872 1093651 1099016 -110299 0 X 0 1 X 1 0 0 0 1 3970000 37486 37486 37486 4217 1943 2274 1003795 738989 264806 267080 DUE TO BIOTECHNOLOGY INNOVATION ORGANIZATION 87684 87684 X 3970902 0 3970902 0 3970902 4081201 0 4081201 0 4081201 PART X, LINE 2: CBI IS EXEMPT FROM FEDERAL TAXES UNDER SECTION 501(C)(6) OF THE INTERNAL REVENUE CODE EXCEPT ON NET INCOME DERIVED FROM UNRELATED BUSINESS ACTIVITIES. CBI REQUIRES THAT A TAX POSITION BE RECOGNIZED OR DERECOGNIZED BASED ON A "MORE-LIKELY-THAN-NOT" THRESHOLD. THIS APPLIES TO POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN. CBI DOES NOT BELIEVE ITS FINANCIAL STATEMENTS INCLUDE, OR REFLECT, ANY UNCERTAIN TAX POSITIONS. CBI'S IRS FORM 990, RETURN OF ORGANIZATION EXEMPT FROM INCOME TAX, IS SUBJECT TO EXAMINATION BY THE TAXING AUTHORITIES, GENERALLY FOR THREE YEARS AFTER IT WAS FILED. NORTH AMERICA - CANADA 0 0 PROGRAM SERVICES CANADA: FOCUSED ON TRAINING THIRD PARTY SPOKESPEOPLE (FARMERS, ACADEMICS, DIETICIANS) TO EDUCATE MEDIA AND PUBLIC ABOUT THE BENEFITS OF AG BIOTECH. 440000 0 0 0 0 0 0 440000 0 440000 0 0 0 0 0 0 PART I, LINE 3: QUARTERLY REPORTS ON ACTIVITIES AND FUNDS SPENT ARE RECEIVED FROM CANADA PROGRAM. X 0 0 0 FORM 990, PART VII, SECTION A, LINE 5, EXECUTIVE OFFICER COMPENSATION FORM 990, PART VII, SECTION A, LINE 5, COMPENSATION FROM UNRELATED ORGANIZATION: IN 2016, KATE HALL SERVED AS ACTING EXECUTIVE DIRECTOR FOR THE COUNCIL FOR BIOTECHNOLOGY INFORMATION. KATE IS EMPLOYED BY BIOTECHNOLOGY INNOVATION ORGANIZATION (FORMERLY BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO)), AN UNRELATED ENTITY TO THE COUNCIL FOR BIOTECHNOLOGY INFORMATION (CBI). MS. HALL PERFORMED WORK FOR CBI AND THE APPROPRIATE AMOUNT OF SALARY AND BENEFITS WERE ALLOCATED TO CBI FROM BIO. TOTAL COMPENSATION: KATE HALL (2016) - COMPENSATION $122,850, BONUS $24,000, BENEFITS $8,683. FORM 990, PART VI, SECTION A, LINE 3 THE EXECUTIVE COMMITTEE RESOLVED TO HAVE THE STEERING COMMITTEE ACT IN AN ADVISORY CAPACITY TO THE EXECUTIVE COMMITTEE; OVERSEE EXECUTION OF PROGRAMS IN THE UNITED STATES, CANADA, AND MEXICO; REVIEW ANNUAL BUDGET REQUESTS AND BUSINESS PLANS; REALLOCATE FUNDS AMONG PROGRAMS, AS NEEDED; AND PERFORM IN SUCH OTHER CAPACITY AS MAY BE DESIGNATED BY THE EXECUTIVE COMMITTEE. CBI HAS NO EMPLOYEES. BIOTECHNOLOGY INNOVATION ORGANIZATION (FORMERLY BIOTECHNOLOGY INFORMATION ORGANIZATION) PROVIDES MANAGEMENT SERVICES TO CBI. FORM 990, PART VI, SECTION A, LINE 6 SENIOR MEMBERSHIP IS OPEN TO SIX FOUNDING MEMBERS AND OTHER CORPORATE ENTITIES THAT MEET SUCH QUALIFICATIONS AS MAY BE ESTABLISHED BY THE EXECUTIVE COMMITTEE. GENERAL MEMBERSHIP IS OPEN TO ANY CORPORATE ENTITY THAT DESIRES TO FURTHER THE PURPOSES OF THE CORPORATION AND MEETS OTHER QUALIFICATIONS AS MAY BE ESTABLISHED BY THE EXECUTIVE COMMITTEE. FORM 990, PART VI, SECTION A, LINE 7A EACH OF THE SENIOR MEMBERS APPOINTS A PERSON TO SERVE ON THE EXECUTIVE COMMITTEE, WHICH MAY EXERCISE ALL POWERS OF THE CORPORATION. FORM 990, PART VI, SECTION B, LINE 11B CBI STAFF PROVIDES THE CBI EXECUTIVE COMMITTEE THE OPPORTUNITY TO REVIEW AND MAKE COMMENTS, VIA EMAIL AND TELECONFERENCE, ON THE FORM PRIOR TO FILING. AFTER FILING, A COPY OF THE FORM 990 WILL BE PROVIDED TO THE EXECUTIVE COMMITTEE MEMBERS. FORM 990, PART VI, SECTION B, LINE 12C CBI HAS A CONFLICT OF INTEREST POLICY AND A PROCESS FOR ENSURING THAT IT IS NOT VIOLATED: AN ANNUAL STATEMENT OF DISCLOSURE IS CIRCULATED TO THE EXECUTIVE COMMITTEE MEMBERS ANNUALLY. THE EXECUTIVE COMMITTEE WILL DETERMINE WHETHER OR NOT A CONFLICT OF INTEREST EXISTS, AND WHETHER OR NOT SUCH CONFLICT MATERIALLY AND ADVERSELY AFFECTS THE INTERESTS OF CBI. AN OFFICER OR DIRECTOR WHOSE POTENTIAL CONFLICT IS UNDER REVIEW MAY NOT DEBATE, VOTE OR OTHERWISE PARTICIPATE IN SUCH DETERMINATION. IF THE EXECUTIVE COMMITTEE DETERMINES THAT AN ACTUAL OR POTENTIAL CONFLICT OF INTEREST DOES EXIST, THE EXECUTIVE COMMITTEE ALSO SHALL DETERMINE AN APPROPRIATE REMEDY. SUCH REMEDY MAY INCLUDE, FOR EXAMPLE, THE RECUSAL OF THE CONFLICTED OFFICER OR DIRECTOR FROM PARTICIPATING IN CERTAIN MATTERS PENDING BEFORE THE EXECUTIVE COMMITTEE OR OTHER CBI BODY. CBI'S INTERNAL GOVERNANCE POLICIES STATE THAT ON AN ANNUAL BASIS, EACH MEMBER OF THE CBI EXECUTIVE COMMITTEE SHALL BE PROVIDED WITH A COPY OF THIS POLICY, AND SHALL COMPLETE AND SIGN THE ACKNOWLEDGEMENT AND DISCLOSURE FORM. FORM 990, PART VI, SECTION B, LINE 15A AS A SHARED EMPLOYEE OF BOTH BIO AND CBI, THE COMPENSATION OF MS. HALL, CBI'S EXECUTIVE DIRECTOR FOR 2016, WAS DETERMINED BY BIO. CBI'S EXECUTIVE COMMITTEE APPROVED THE TIME ALLOCATION TO BE REIMBURSED BY CBI FOR MS. HALL'S TIME ALLOCATION IN 2016. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE NOT MADE AVAILABLE TO THE PUBLIC. CBI COMPLIES WITH THE PUBLIC INSPECTION REQUIREMENTS OF INTERNAL REVENUE CODE SECTION 6104 BY MAKING ITS FORM 1024, APPLICATION FOR RECOGNITION OF EXEMPTION UNDER SECTION 501(A), DETERMINATION LETTER FROM THE IRS, AND THE FORMS 990 FOR ITS THREE MOST RECENTLY COMPLETED TAX PERIODS. HOWEVER, AS SECTION 6104 DOES NOT REQUIRE ORGANIZATIONS EXEMPT UNDER SECTION 501(C)(6) TO DISCLOSE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICIES, OR FINANCIAL STATEMENTS, CBI HAS CHOSEN NOT TO MAKE SUCH INFORMATION AVAILABLE FOR PUBLIC INSPECTION. FORM 990, PART IX, LINE 11G CONSULTING FEES INCURRED FOR GMO ANSWERS CONSULTANT 2,858,000. CONTRACTUAL SERVICES FOR CANADA PROGRAMS 440,000. CONSULTING FEES FOR ADVERTORIALS 39,000. CONSULTING FEES FOR JUNE 2016 EVENT 1,800.